Asymmetric dimethylarginine serum levels are associated with patient characteristics after renal transplant
Asymmetric dimethylarginine serum levels are associated with patient characteristics after renal transplant
To investigate the changes in asymmetric plasma dimethylarginine (ADMA) levels after six months of renal transplant and their potential associations with patient characteristics. Subjects and methods: From March 2018 to April 2020, a prospective enrolled 75 recipients 6 months after renal transplant at Military Hospital 103.